Last reviewed · How we verify

Midazolam and Qualaquin at steady state

Mutual Pharmaceutical Company, Inc. · Phase 1 active Small molecule

Midazolam and Qualaquin at steady state is a Small molecule drug developed by Mutual Pharmaceutical Company, Inc.. It is currently in Phase 1 development. Also known as: midazolam, Qualaquin, quinine sulfate.

At a glance

Generic nameMidazolam and Qualaquin at steady state
Also known asmidazolam, Qualaquin, quinine sulfate
SponsorMutual Pharmaceutical Company, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Midazolam and Qualaquin at steady state

What is Midazolam and Qualaquin at steady state?

Midazolam and Qualaquin at steady state is a Small molecule drug developed by Mutual Pharmaceutical Company, Inc..

Who makes Midazolam and Qualaquin at steady state?

Midazolam and Qualaquin at steady state is developed by Mutual Pharmaceutical Company, Inc. (see full Mutual Pharmaceutical Company, Inc. pipeline at /company/mutual-pharmaceutical-company-inc).

Is Midazolam and Qualaquin at steady state also known as anything else?

Midazolam and Qualaquin at steady state is also known as midazolam, Qualaquin, quinine sulfate.

What development phase is Midazolam and Qualaquin at steady state in?

Midazolam and Qualaquin at steady state is in Phase 1.

Related